Key facts
- It has raised $200K across 1 recorded rounds; the latest was Seed Round ($500K) in May 2026.
- Notable investors include MedTech Innovator, BioTools Innovator.
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for ReelReactor
Funding rounds
1 roundsAbout ReelReactor
Developer of reactor technologies designed to increase efficiency and quality of various chemical, pharmaceutical, and biological products and therapies. The company's technology has the potential to reduce costs and improve product quality and consistency, enabling clients to make therapies accessible at a low cost.
- Sector
- Healthcare
- HQ
- Boise, ID, United States
- Founded
- 2018
- Website
- reelreactor.com/
- Ownership
- Privately Held (backing)
ReelReactor doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ReelReactor shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ReelReactor in its N-PORT filings yet. We sweep new filings monthly.